Over the last few years, the landscape of metabolic health and weight management has actually been changed by a class of medications understood as GLP-1 receptor agonists. These treatments, originally developed for Type 2 diabetes, have acquired international attention for their efficacy in dealing with weight problems. In Germany, a nation known for its extensive medical standards, the digital healthcare transformation— sped up by the intro of the E-Rezept (e-prescription)— has actually made it increasingly possible for clients to access these medications through regulated online platforms.

This article provides an in-depth expedition of the telemedical landscape for GLP-1 prescriptions in Germany, outlining the legal structure, the procedure of obtaining an online prescription, and the security considerations every client should understand.

Understanding GLP-1 Medications

GLP-1 (Glucagon-like peptide-1) receptor agonists imitate a naturally taking place hormonal agent in the body. This hormonal agent is accountable for stimulating insulin secretion, slowing gastric emptying, and signaling satiety to the brain. By improving these paths, the medication assists clients manage blood glucose levels and substantially lower body weight.

Typical GLP-1 Medications Available in Germany

Brand Name

Active Ingredient

Main Indication

Administration

Ozempic

Semaglutide

Type 2 Diabetes

Weekly Injection

Wegovy

Semaglutide

Weight Management

Weekly Injection

Mounjaro

Tirzepatide

Diabetes/ Weight Mgmt

Weekly Injection

Saxenda

Liraglutide

Weight Management

Daily Injection

Rybelsus

Semaglutide

Type 2 Diabetes

Daily Oral Tablet

While Ozempic and Wegovy contain the very same active ingredient (Semaglutide), they are certified for various purposes in Germany. Wegovy is particularly approved for chronic weight management in patients with a BMI over 30, or over 27 with weight-related comorbidities.

The Legal Framework for Telemedicine in Germany

Germany has traditionally been conservative regarding digital health. Nevertheless, Mehr erfahren -Gesetz” (Digital Act) and the nationwide rollout of the E-Rezept have smoothed the course for telemedicine. To legally get a GLP-1 prescription online in Germany, several conditions should be fulfilled:

1. Doctor-Patient Interaction: A medical assessment must happen. While this can take place via a digital questionnaire or video call, it should be examined by a certified doctor.
2. Prescription Requirement: All GLP-1 medications are verschreibungspflichtig (prescription-only). Offering these drugs without a prescription is illegal and a significant safety danger.
3. Drug store Fulfillment: Online prescriptions need to be sent to a licensed physical or mail-order drug store (Apotheke).

How to Obtain a GLP-1 Prescription Online

The process of protecting a GLP-1 prescription through a trusted German or EU-licensed telemedical platform normally follows a standardized treatment to guarantee client security.

Step-by-Step Process

1. Online Health Assessment: The client completes a comprehensive medical survey. This includes providing current weight, height (BMI calculation), case history, and high blood pressure readings.
2. Medical Review: A certified medical professional evaluates the information. They might request additional information, such as recent lab outcomes (e.g., HbA1c levels or kidney function tests) or a photo to verify identity and body habitus.
3. Choice of Treatment: If the client is considered qualified based upon BMI and health history, the physician issues a digital prescription (E-Rezept).
4. Pharmacy Dispatch: The prescription is forwarded to a partner pharmacy. The medication is then shipped to the patient in temperature-controlled packaging, as GLP-1 analogs usually need refrigeration.

Expenses and Insurance Coverage

One of the most complicated aspects of GLP-1 therapy in Germany is the expense. The repayment structure depends upon the patient's insurance coverage type and the particular medical diagnosis.

Statutory Health Insurance (Gesetzliche Krankenversicherung – GKV)

Under current German law (particularly § 20 SGB V), medications used mainly for weight-loss are frequently categorized as “lifestyle drugs.” Subsequently, the GKV typically does not cover the cost of Wegovy or Saxenda for weight management. However, if Ozempic or Mounjaro is prescribed for Type 2 Diabetes, it is normally covered, with the client just paying the basic co-payment (Zuzahlung).

Private Health Insurance (Private Krankenversicherung – PKV)

Private insurers might cover GLP-1 treatments for weight problems if a medical necessity is proven. Clients are recommended to obtain a cost-absorption declaration (Kostenübernahmeerklärung) from their company before starting treatment.

Self-Payers (Selbstzahler)

Many patients in Germany choose to pay for Wegovy or Mounjaro out-of-pocket. The month-to-month expense can range from EUR170 to over EUR300, depending upon the dosage and the particular medication.

Benefits and Risks of Online Prescriptions

Benefits

• Benefit: Patients can prevent long waiting times at professional clinics (Endocrinologists).
• Discretion: Weight management is a sensitive topic; online consultations supply a level of privacy some clients prefer.
• Constant Care: Many online platforms provide subscription designs that consist of routine check-ins and titration (steady dosage boosts).

Drawbacks and Risks

• Absence of Physical Examination: An online physician can not carry out a physical palpation of the thyroid or a cardiovascular exam.
• Counterfeit Products: Due to high demand/shortages, many deceptive websites use “generic Ozempic.” In Germany, these are often illegal and hazardous.
• Negative Effects Management: GLP-1s can cause serious nausea, throwing up, or unusual issues like pancreatitis. Remote monitoring requires the patient to be extremely proactive in reporting signs.

Safety Checklist for Online GLP-1 Providers

Patients need to exercise care when picking a service provider. A legitimate German telemedical service should satisfy the following criteria:

• EU Licensing: The provider must be signed up within the EU and utilize doctors accredited to practice in Germany or recognized EU jurisdictions.
• Comprehensive Assessment: Avoid any website that uses the drug after just a few clicks or without a medical survey.
• Validated Pharmacies: The service must work just with registered German pharmacies (try to find the “Green Cross” or main register).
• No “Off-Label” Promotion: While medical professionals can recommend off-label, credible sites must not actively market Ozempic for weight reduction, as Wegovy is the approved alternative for that sign.

Summary of the Current Market

The demand for GLP-1s in Germany has actually resulted in occasional supply lacks. Telemedical platforms often have much better exposure into stock levels throughout different pharmacies than private local chemists might.

Feature

Local GP/Specialist

Trusted Online Platform

Accessibility

Based on local consultation slots

24/7 Access

Insurance coverage Billing

Direct (GKV-ready)

Usually Private/Self-pay

Monitoring

In-person examinations

Digital check-ins

Cost

Assessment covered by GKV

Assessment cost (approx. EUR20— EUR50)

Obtaining GLP-1 prescriptions online in Germany has actually ended up being a practical and safe alternative for lots of, offered they utilize controlled channels. The integration of the E-Rezept has actually improved this procedure, permitting for seamless communication between physicians, clients, and pharmacies. While the expenses can be high for those utilizing the medication for weight management, the accessibility provided by telemedicine represents a substantial advance in dealing with metabolic health in the digital age.

• * *

Regularly Asked Questions (FAQ)

1. Is it legal to buy Ozempic online in Germany?

It is legal to obtain a prescription through a regulated telemedical platform and have it filled by a licensed pharmacy. It is prohibited to acquire it from sites that do not require a prescription or a medical assessment.

2. Does the GKV (Statutory Insurance) pay for Wegovy?

Typically, no. In Germany, Wegovy is currently excluded from the list of reimbursable drugs by statutory insurance providers because it is categorized under weight loss/lifestyle treatments.

3. How do I know if an online physician is genuine?

Genuine platforms will show their impressum, offer the names of the medical professionals, and be signed up with the appropriate medical chambers (Ärztekammer) or EU regulative bodies.

4. What takes place if I have adverse effects?

Clients need to get in touch with the telemedical supplier's support or their regional physician right away. The majority of online platforms have a procedure for “titration,” where the dosage is changed or stopped briefly based upon the patient's tolerance.

5. Can I get a prescription if my BMI is listed below 27?

Normally, no. German medical standards for GLP-1s specifically for weight-loss require a BMI of at least 30, or 27 with at least one weight-related health concern (like high blood pressure or sleep apnea).

6. Do I require to offer blood tests?

While not always needed for the initial prescription, lots of accountable medical professionals will request for current blood work (within the last 3-6 months) to guarantee your kidney, pancreas, and thyroid functions are normal.

Recently, the landscape of metabolic health and weight management has been transformed by a class of drugs referred to as GLP-1 receptor agonists. GLP-1-Injektionen in Deutschland -Like Peptide-1, these medications— originally established to treat Type 2 diabetes— have actually gotten international popularity for their effectiveness in chronic weight management. In Germany, the need for these treatments has surged, resulting in questions concerning availability, insurance coverage, and, most significantly, price.

For lots of living in Germany, navigating the healthcare system to find inexpensive GLP-1 options requires an understanding of regulatory laws, insurance coverage categories, and the present market value. This guide explores the accessibility and costs of GLP-1 medications within the German “Gesundheitssystem.”

• * *

What are GLP-1 Medications?

GLP-1 receptor agonists work by imitating a natural hormone in the body that manages blood sugar levels and cravings. By slowing gastric emptying and signaling satiety to the brain, these medications help clients lose substantial weight and manage insulin levels.

In Germany, the most typical GLP-1 medications consist of:

• Semaglutide (Ozempic, Wegovy)
• Liraglutide (Saxenda, Victoza)

• Tirzepatide (Mounjaro— a dual GIP/GLP -1 agonist)

• • *

The Cost Structure in Germany

The cost of GLP-1 medications in Germany is managed, however the “out-of-pocket” cost for a patient depends greatly on their insurance coverage status and the primary factor for the prescription.

1. Statutory Health Insurance (GKV)

For patients with Type 2 diabetes, GLP-1 medications like Ozempic or Mounjaro are usually covered by statutory health insurance (Gesetzliche Krankenversicherung). In these cases, the patient pays only a small co-payment (Zuzahlung), typically in between EUR5 and EUR10.

Nevertheless, a substantial obstacle exists for weight-loss. Under Section 34 of the Social Code Book V (SGB V), medications categorized as “lifestyle drugs”— consisting of those for weight loss— are omitted from the list of reimbursable costs by GKV. This implies that even if a medical professional prescribes Wegovy for weight problems, the client must typically pay the full cost.

2. Private Health Insurance (PKV)

Private insurance providers (Private Krankenversicherung) have more versatility. Depending on the particular tariff and medical requirement, some personal insurers may compensate the expense of GLP-1 medications for weight problems, particularly if the patient has considerable comorbidities like hypertension or sleep apnea.

3. Out-of-Pocket (Selbstzahler)

Patients who do not meet the requirements for insurance protection need to get a private prescription (Privatrezept) and pay the drug store's retail cost.

• * *

Comparison of GLP-1 Medications in Germany

The following tables offer an introduction of the most typical GLP-1 medications available in German drug stores and their estimated expenses.

Table 1: GLP-1 Medication Profiles

Medication

Active Ingredient

Primary Indication

German Approval

Ozempic

Semaglutide

Type 2 Diabetes

Authorized

Wegovy

Semaglutide

Weight Problems/ Weight Management

Approved

Mounjaro

Tirzepatide

Diabetes & & Weight Management

Authorized

Saxenda

Liraglutide

Weight Problems/ Weight Management

Approved

Victoza

Liraglutide

Type 2 Diabetes

Authorized

Table 2: Estimated Monthly Costs (Out-of-Pocket)

Note: Prices are subject to alter based upon dosage and drug store markups.

Medication

Common Monthly Dose

Estimated Monthly Price (Private)

Ozempic

0.5 mg – 1.0 mg

EUR80 – EUR120

Wegovy

2.4 mg

EUR170 – EUR300

Mounjaro

5 mg – 15 mg

EUR250 – EUR400

Saxenda

3.0 mg (Daily)

EUR200 – EUR290

• * *

Strategies for Finding Affordable GLP-1 Options

While many GLP-1 drugs carry a high price, there are a number of methods clients in Germany can handle the monetary problem.

1. Medical Necessity Documentation

For those with a high Body Mass Index (BMI) and health issues, having a GP or endocrinologist provide detailed paperwork may help in interesting medical insurance providers. While GKV is strictly bound by law, some “Sonderregelungen” (unique guidelines) may periodically use if the weight problems is secondary to another condition.

2. Selecting the Right Medication

While Mounjaro and Wegovy are the “gold requirements” for weight reduction, they are frequently the most expensive. Some medical professionals may prescribe Liraglutide (Saxenda), which, although required daily, might often be found by means of online pharmacy discounts.

3. Bigger Pack Sizes

In Germany, buying a three-month supply (N3 package size) is often more affordable than buying a one-month supply. The cost per dose substantially reduces when purchasing wholesale.

4. Telemedicine Platforms

A number of licensed German telemedicine platforms (such as Zava or Couch: now) use consultations for GLP-1 prescriptions. While the medication expense stays similar, these platforms can provide a more structured and often more inexpensive path to the essential personal prescription than going to several personal professionals.

• * *

Regulative and Safety Warnings

Due to the high need and lacks (Lieferengpässe), there has actually been a rise in “intensified” semaglutide or “gray market” imports. It is essential for patients in Germany to stay conscious of the following:

• Avoid Illegal Imports: Buying GLP-1 medications from non-EU websites is prohibited in Germany and carries high dangers of counterfeit items.
• BfArM Monitoring: The Federal Institute for Drugs and Medical Devices (BfArM) strictly monitors the supply of Ozempic to guarantee diabetic clients have concern. Clients seeking these drugs for weight reduction ought to stay with Wegovy or Mounjaro to prevent depleting diabetic products.

• No Generic Options (Yet): As these are still under patent security, there are no legal “generic” GLP-1 medications in Germany. Any item declaring to be a generic semaglutide is most likely unauthorized.

• • *

Actions to Obtain a Prescription in Germany

1. Initial Consultation: Visit a Hausarzt (GP) or an Endokrinologe (Endocrinologist) to go over metabolic health.
2. Blood Work: The doctor will examine HbA1c levels, liver enzymes, and kidney function.
3. The Prescription:
   • Pink Prescription: For GKV patients (Diabetes only).
   • Blue/Green Prescription: For private patients or “Selbstzahler” (Weight loss).
4. Drug store Fulfillment: Present the prescription at a regional or online drug store. If the drug is not in stock, the pharmacist can check the “Lieferbarkeit” (accessibility) throughout local wholesalers.

• * *

Regularly Asked Questions (FAQ)

Is Wegovy more affordable in Germany than in the USA?

Yes, Wegovy is significantly more inexpensive in Germany than in the United States. While US clients might pay over ₤ 1,000 monthly without insurance coverage, the German retail price is capped considerably lower, normally under EUR300.

Can I get Ozempic for weight-loss in Germany?

While a physician can technically prescribe it “off-label,” German authorities have highly discouraged this due to shortages affecting diabetic patients. Most doctors will now prescribe Wegovy (the very same component, semaglutide, however branded for weight-loss) rather.

Will the Krankenkasse ever spend for weight reduction GLP-1s?

There is continuous political debate in Germany regarding this concern. While the current law classifies them as lifestyle drugs, medical associations are lobbying to have actually weight problems recognized as a persistent illness needing covered pharmaceutical intervention.

Are there any “cost effective” alternatives?

If GLP-1s are financially out of reach, patients can talk about older weight-loss medications with their doctor, such as Orlistat or Mysimba, which are normally less expensive however frequently less efficient for significant weight reduction.

• * *

Getting budget-friendly GLP-1 medications in Germany is a process of browsing insurance rules and comprehending market pricing. While diabetic patients take pleasure in high levels of protection, those seeking treatment for weight problems face higher out-of-pocket costs. However, compared to lots of other global markets, Germany's regulated prices makes these life-changing medications fairly accessible. Prioritizing an assessment with a metabolic specialist is the first and most essential step towards a cost effective and safe treatment strategy.

The landscape of metabolic health and weight management has undergone a significant improvement with the intro of glucagon-like peptide-1 (GLP-1) receptor agonists. In Germany, medications such as Ozempic ®, Wegovy ®, and Mounjaro ® have seen a rise in need, driven by their efficacy in dealing with Type 2 diabetes and persistent obesity. Nevertheless, the German health care system preserves strict guidelines regarding how these medications are prescribed and given. This guide provides a thorough summary of how to lawfully and safely order GLP-1 medications in Germany, the expenses involved, and the regulatory framework governing their use.

Understanding GLP-1 Medications

GLP-1 receptor agonists are a class of drugs that simulate the natural hormone GLP-1, which is produced in the gut. These medications perform a number of important functions: they stimulate insulin secretion, inhibit glucagon release, slow gastric emptying, and increase the sensation of satiety (fullness) in the brain.

Initially established entirely for the management of Type 2 diabetes, scientific trials eventually showed significant weight-loss benefits for clients without diabetes, resulting in the approval of particular brands for weight management. In Germany, while several of these drugs include the exact same active components, they are licensed for various therapeutic indicators.

Typical GLP-1 Medications Available in Germany

Brand

Active Ingredient

Primary Indication

Administration Frequency

**Ozempic ® Semaglutide Type 2 Diabetes Weekly Injection Wegovy ®

Semaglutide Weight Management Weekly Injection

**

Mounjaro

® Tirzepatide Diabetes & Weight Loss Weekly

Injection

Victoza ®

Liraglutide

Type 2 Diabetes Daily Injection Saxenda ® Liraglutide Weight Management Daily Injection

Rybelsus ® Semaglutide Type 2 Diabetes Daily Oral Tablet The

Legal Process of Ordering GLP-1 in Germany In Germany

, all GLP-1

medications

are categorized as rezeptpflichtig(prescription-only). It is unlawful

to acquire

these medications

without a valid

prescription from a

physician registered in the EU/EEA. The process of

acquiring these medications includes several obligatory steps created to ensure client security and medical requirement. 1. Medical Consultation The initial step is a consultation with a healthcare expert. This can be a regional General Practitioner(GP), an endocrinologist, or a specialist at an acknowledged obesity clinic. Throughout this visit, the

doctor evaluates the patient's medical history, present Body Mass Index( BMI ), and comorbidities (such as hypertension or dyslipidemia ). 2. Diagnostic Testing Before a prescription is issued, blood tests are usually required. These tests keep track of HbA1c levels (for diabetes), kidney function, and pancreatic enzymes.

Due to the fact that GLP-1 medications bring threats— such as pancreatitis or gallbladder concerns— an extensive screening is vital. 3. Issuance of the Prescription If the doctor deems the treatment ideal, they will issue one of two kinds of prescriptions: Kassenrezept(Pink Prescription ): For patients with statutory medical insurance (GKV)where the

medication is covered for diabetes treatment. Privatrezept(Blue or White Prescription ): For clients paying out-of-pocket or those with private medical insurance(PKV* ). Presently, most GLP-1 medications recommended particularly for weight loss (like Wegovy )are issued on a personal prescription, as statutory insurance companies generally do not cover”lifestyle “weight-loss medications. 4. Fulfillment at a Licensed Pharmacy When a prescription is gotten, it can be filled at any fixed drug store(Apotheke)or a licensed German mail-order drug store(Versandapotheke ). Due to the temperature-sensitive nature of these injections, drug stores need to ensure a constant cold chain during storage and transportation. Telemedicine and Online Ordering The rise of telemedical platforms in Germany has actually simplified the procedure of ordering_GLP-1 medications, provided these platforms run within the legal framework of the Fernbehandlungsgesetz(Telemedicine Law). Clients may utilize certified platforms(such as Zava, TeleClinic, or specialized weight-loss programs like Oviva)to talk to

a physician via video or digital

questionnaire. If approved, an electronic prescription (E-Rezept) is generated. This digital prescription is then sent directly to a partner pharmacy, which delivers the _medication to the patient's home. Warning: Patients must

be extremely careful of sites offering GLP-1 medications without a medical consultation or prescription. These sites often sell fake or unregulated products that position extreme health risks. Cost and Insurance Coverage in Germany The expense of GLP-1 therapy in Germany varies considerably depending upon the patient's insurance status and the particular indication for the drug.

Statutory Health Insurance(GKV)For patients identified with Type 2 diabetes, the GKV normally covers the expense of medications like Ozempic or Mounjaro. The patient just pays a little co-payment (Zuzahlung), typically between EUR5 and EUR10 per pack.

Nevertheless, the G-BA(Federal Joint Committee ———————————————————————

)presently omits medications intended simply for weight loss from the list of reimbursable drugs. For that reason, even if a client is severely overweight

### , the GKV will rarely cover Wegovy or Saxenda. Private Health Insurance (PKV)Private insurance providers often have more versatility. Numerous PKV providers will reimburse the costs of GLP-1 medications for weight problems if the patientsatisfies particular requirements(e.g., BMI > 30 or BMI > 27 with comorbidities). Patients are encouraged to acquire a cost-absorption declaration (Kostenübernahmeerklärung)from their insurance provider before starting treatment. Self-Payers If a client does not fulfill insurance requirements for protection, they must pay the full list price.

_

### Wegovy: Prices generally range from EUR170 to EUR300 each month, depending on the dose. Ozempic: While intended for diabetes, when recommended off-label for weight loss on a personal prescription, it costs around EUR80 to EUR100 for a one-month supply(though supply scarcities often make it difficult to acquire for non-diabetic usage). Criteria for Eligibility Physicians in Germany usually follow the guidelines supplied by the European Medicines Agency( EMA) and German medical societies. For Weight Management(e.g., Wegovy ): A BMI of 30 kg/m ² or

* higher (Obesity). A BMI of 27 kg/m two to 30 kg/m ² (Overweight)in the presence of at * least one weight-related comorbid condition such as hypertension, Type 2 diabetes, or dyslipidemia. The medication needs to be used as an adjunct to a reduced-calorie diet and increased physical activity. For Type 2 Diabetes (e.g., Ozempic, Mounjaro):

Insufficiently controlled ————————————-

blood glucose levels regardless of oral medications (like Metformin )or as a first-line therapy if Metformin is not tolerated. List: Safety Precautions and Best Practices When ordering and using GLP-1 medications in Germany, clients

* should abide by the following safety procedures: Verify the Pharmacy: Ensure the online pharmacy carries the official “EU safety logo design”for medication merchants. Maintain the Cold Chain: GLP-1 injectors must be kept in the fridge(2 ° * C to 8 ° C). As soon as in usage, they can often remain at room temperature for a minimal duration (examine the particular leaflet

**). Monitor Side Effects: Common negative effects include queasiness, vomiting

* , and diarrhea. If severe abdominal pain happens, clients should look for medical attention right away to eliminate pancreatitis. Prevent “Off-Label “Pressure: Do not pressure

doctors for Ozempic prescriptions if you do not have diabetes; this adds to scarcities for diabetic clients who rely on the drug for survival. Look for Counterfeits: ——————————————————————————————————————————————————————————————————————————————————-

**

* *Look for the “2D Data Matrix”code and the anti-tampering seal on the product packaging, as needed by the securPharm system in Germany. Often Asked Questions (FAQ )1. Can I buy Ozempic over-the-counter in Germany? No. Ozempic and all other GLP-1 agonists are strictly prescription-only. Offering or buying these drugs without a prescription is a violation of the German Medicines Act (Arzneimittelgesetz). 2. Is there a lack of GLP-1 medications in Germany? Yes, there have been intermittent supply scarcities of Ozempic and Wegovy due to high global demand. The German regulatory authority(BfArM)has actually * issued recommendations to prioritize supplies for diabetic patients. 3. Can I utilize an E-Prescription for GLP-1? Yes. Since 2024, the E-Prescription (E-Rezept )is the standard in Germany. You can redeem it utilizing your health insurance coverage card, an app, or a printed QR code at any pharmacy. 4. Are GLP-1 tablets as efficient as injections? Rybelsus is a GLP-1 agonist in tablet kind. While reliable for blood glucose control, scientific data recommends**

that high-dose injections (like ———————————————-

### Wegovy) generally result in higher weight

loss for the majority of patients compared to the presently available oral dosages. 5. What takes GLP-1 in Deutschland kaufen if I stop taking the medication? Scientific studies show that a lot of clients gain back a considerable part of their lost weight if they discontinue the medication without having actually developed irreversible lifestyle modifications. GLP-1 treatment is often viewed as a long-term treatment. Purchasing GLP-1 medications in Germany is a structured process designed to focus on client security. While the rise of telemedicine has actually made gain access to more practical, the necessity of a medical diagnosis and a valid

prescription remains outright. Patients thinking about these treatments should talk to their physician to go over the dangers and advantages, and ensure they are getting their medication through legitimate, licensed pharmaceutical channels. As the supply

chain supports and insurance policies evolve, GLP-1 agonists will continue to play a critical function in Germany's method to metabolic health.

————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————_